Cargando…
4-Methylumbeliferone Treatment at a Dose of 1.2 g/kg/Day Is Safe for Long-Term Usage in Rats
4-methylumbelliferone (4MU) has been suggested as a potential therapeutic agent for a wide range of neurological diseases. The current study aimed to evaluate the physiological changes and potential side effects after 10 weeks of 4MU treatment at a dose of 1.2 g/kg/day in healthy rats, and after 2 m...
Autores principales: | Štěpánková, Kateřina, Mareková, Dana, Kubášová, Kristýna, Sedláček, Radek, Turnovcová, Karolína, Vacková, Irena, Kubinová, Šárka, Makovický, Pavol, Petrovičová, Michaela, Kwok, Jessica C. F., Jendelová, Pavla, Machová Urdzíková, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959083/ https://www.ncbi.nlm.nih.gov/pubmed/36835210 http://dx.doi.org/10.3390/ijms24043799 |
Ejemplares similares
-
The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury
por: Chudickova, Milada, et al.
Publicado: (2019) -
The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application
por: Krupa, Petr, et al.
Publicado: (2018) -
Low oral dose of 4-methylumbelliferone reduces glial scar but is insufficient to induce functional recovery after spinal cord injury
por: Štepánková, Kateřina, et al.
Publicado: (2023) -
Planet of the AAVs: The Spinal Cord Injury Episode
por: Stepankova, Katerina, et al.
Publicado: (2021) -
The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury
por: Machova Urdzikova, Lucia, et al.
Publicado: (2023)